4//SEC Filing
Mirati Therapeutics, Inc. 4
Accession 0001190725-16-000527
CIK 0001576263operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:24 PM ET
Size
8.4 KB
Accession
0001190725-16-000527
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2016-10-03+120,000→ 120,000 totalExercise: $6.45Exp: 2026-10-02→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001576263
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:24 PM ET
- Size
- 8.4 KB